NDTV

Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The treatment is a once-nightly oral pill designed specifically for obstructive sleep apnea.

New Delhi, April 3 (IANS) Scientists have found that those living with obstructive sleep apnea (OSA) have a 71 per cent higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA.

Perimenopause can begin years before menopause, with symptoms like anxiety, fatigue and poor sleep often mistaken for stress. Experts say early recognition, lifestyle changes and timely care can help women manage this transition better.

Scientists in Bengaluru have identified a single genetic cause linking dilated cardiomyopathy, obesity and sleep apnea (DOSA), a breakthrough that may help explain why these conditions co-occur and lead to better screening and treatments for at-risk